Woodline Partners’s Hims & Hers Health HIMS Stock Holding History

Woodline Partners’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-152,428	Closed	-$3.16M	–	1082
2026 Q1	$3.16M	Buy	+152,428	New	+$3.6M	0.01%	740
2022 Q4	–	Sell	-290,278	Closed	-$1.62M	–	796
2022 Q3	$1.62M	Buy	+290,278	New	+$1.75M	0.02%	486

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Woodline Partners's HIMS Position: Q2 2026 in Review

Woodline Partners sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 152,428 shares — an estimated $3.16M sold.

Woodline Partners first reported a position in HIMS in Q3 2022 and held it in 2 quarters. The position peaked at $3.16M in Q1 2026. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Woodline Partners reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
Woodline Partners sold 152,428 Hims & Hers Health shares in Q2 2026, an estimated $3.16M.
Woodline Partners first reported a position in Hims & Hers Health in Q3 2022 and held it in 2 quarters.
Woodline Partners's Hims & Hers Health position peaked at $3.16M in Q1 2026.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.